Asklepios Kliniken Hamburg GmbH

Asklepios Kliniken Hamburg GmbH is a company in Hamburg, Germany that has taken part in 4 EU-funded projects since 2017, receiving €1.1M in EU funding.

EU funding received€1.1M
EU projects4
As coordinator0
Running now3
First EU project2017
Latest project2025
CountryGermany
EU registration (PIC)917347431
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Asklepios Kliniken Hamburg GmbH's own share of each project, not the project's full budget.

  • Horizon Europe€1.0M · 3 projects
  • Horizon 2020€100k · 1 project

Projects

4 EU-funded projects, newest first. Each links to the official record.

  • HealthIntelActAssociated partner

    Actionable Performance Intelligence towards Health and Care Systems for People, Planet, and Prosperity

    Horizon Europe · 2025–2028 · Project on CORDIS ↗

  • VASCUL-AIDAssociated partner

    DEVELOPING TRUSTWORTHY ARTIFICIAL INTELLIGENCE (AI)-DRIVEN TOOLS TO PREDICT VASCULAR DISEASE RISK AND PROGRESSION

    Horizon Europe · 2023–2029 · Project on CORDIS ↗

    €332ktheir share
  • IDERHAPartner

    Integration of heterogeneous Data and Evidence towards Regulatory and HTA Acceptance

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €707ktheir share
  • PACEPartner

    A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €100ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • artificial intelligence
  • cardiovascular diseases
  • cells technologies
  • civil society
  • comets
  • data science
  • diabetes
  • governance
  • lung cancer
  • machine learning
  • mortality
  • peripheral vascular disease
  • personalized medicine
  • pharmaceutical drugs

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime